Synergistic combined effect between CD40-1C>T and CTLA-4+6230G>A polymorphisms in Graves' disease

Gene

Volumn 567, Issue 2, 2015, Pages 154-158

  Chen, Xiaoming ^a   Hu, Zhuoqing ^a   Li, Wei ^a   Wu, Ping ^a   Liu, Meilian ^a   Bao, Liwen ^a   Wu, Meifen ^a   Fang, Shuo ^a   Xiong, Wei ^a   Chen, Manyang ^a   Wu, Ge ^a  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

Author keywords

CD40; CTLA 4; Genetic polymorphism; Graves' disease

Indexed keywords

CD40 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; THYROTROPIN RECEPTOR ANTIBODY;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; GRAVES DISEASE; HIGH RESOLUTION MELTING ANALYSIS; HUMAN; IMMUNOGENETICS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; ADOLESCENT; CASE CONTROL STUDY; DNA SEQUENCE; EPISTASIS; GENETICS; MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIGENS, CD40; CASE-CONTROL STUDIES; CTLA-4 ANTIGEN; EPISTASIS, GENETIC; FEMALE; GENE FREQUENCY; GENOME-WIDE ASSOCIATION STUDY; GRAVES DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE ANALYSIS, DNA; YOUNG ADULT;

EID: 84937634779     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2015.04.074     Document Type: Article

References (27)

1. Chu X., Pan C.M., Zhao S.X., Liang J., Gao G.Q., Zhang X.M., Yuan G.Y., Li C.G., Xue L.Q., Shen M., Liu W., Xie F., Yang S.Y., Wang H.F., Shi J.Y., Sun W.W., Du W.H., Zuo C.L., Shi J.X., Liu B.L., Guo C.C., Zhan M., Gu Z.H., Zhang X.N., Sun F., Wang Z.Q., Song Z.Y., Zou C.Y., Sun W.H., Guo T., Cao H.M., Ma J.H., Han B., Li P., Jiang H., Huang Q.H., Liang L., Liu L.B., Chen G., Su Q., Peng Y.D., Zhao J.J., Ning G., Chen Z., Chen J.L., Chen S.J., Huang W., Song H.D. A genome-wide association study identified two new risk loci for Graves' disease. Nat. Genet. 2011, 43(9):897-901.
2. Cunninghame-Graham D.S., Wong A.K., McHugh N.J., Whittaker J.C., Vyse T.J. Evidence for unique association signals in SLE at the CD28-CTLA4-ICOS locus in a family-based study. Hum. Mol. Genet. 2006, 5(21):3195-3205.
3. Daroszewski J., Pawlak E., Karabon L., Frydecka I., Jonkisz A., Slowik M., Bolanowski M. Soluble CTLA-4 receptor an immunological marker of Graves' disease and severity of ophthalmopathy is associated with CTLA-4 Jo31 and CT60 gene polymorphisms. Eur. J. Endocrinol. 2009, 161(5):787-793.
4. Du L., Yang J., Huang J., Ma Y., Wang H., Xiong T., Xiang Z., Zhang Y., Huang J. The associations between the polymorphisms in the CTLA-4 gene and the risk of Graves' disease in the Chinese population. BMC Med. Genet. 2013, 14:46.
5. Effraimidis G., Wiersinga W.M. Mechanisms in endocrinology: autoimmune thyroid disease: old and new players. Eur. J. Endocrinol. 2014, 170(6):R241-R252.
6. Gillespie E.F., Raychaudhuri N., Papageorgiou K.I., Atkins S.J., Lu Y., Charara L.K., Mester T., Smith T.J., Douglas R.S. Interleukin-6 production in CD40-engaged fibrocytes in thyroid-associated ophthalmopathy: involvement of Akt and NF-κB. Invest. Ophthalmol. Vis. Sci. 2012, 53(12):7746-7753.
7. Gong F.L. Medical Immunology 2012, Science press, China, Beijing.
8. Hasham A., Tomer Y. Genetic and epigenetic mechanisms in thyroid autoimmunity. Immunol. Res. 2012, 54(1-3):204-213.
9. Huber A.K., Finkelman F.D., Li C.W., Concepcion E., Smith E., Jacobson E., Latif R., Keddache M., Zhang W., Tomer Y. Genetically driven target tissue overexpression of CD40: a novel mechanism in autoimmune disease. J. Immunol. 2012, 189(6):3043-3053.
10. Inoue N., Watanabe M., Yamada H., Takemura K., Hayashi F., Yamakawa N., Akahane M., Shimizuishi Y., Hidaka Y., Iwatani Y. Associations between autoimmune thyroid disease prognosis and functional polymorphisms of susceptibility genes, CTLA4, PTPN22, CD40, FCRL3, and ZFAT, previously revealed in genomewide association studies. J. Clin. Immunol. 2012, 32(6):1243-1252.
11. Kolar P., Knieke K., Hegel J.K., et al. CTLA-4 (CD152) controls homeostasis and suppressive capacity of regulatory T cells in mice. Arthritis Rheum. 2009, 60:123-.
12. Kouki T., Gardine C.A., Yanagawa T., De Groot L.J. Relation of three polymorphisms of the CTLA-4 gene in patients with Graves' disease. J. Endocrinol. Invest. 2002, 25(3):208-213.
13. Li M., Sun H., Liu S., Yu J., Li Q., Liu P., Shen H., Sun D. CD40 C/T-1 polymorphism plays different roles in Graves' disease and Hashimoto's thyroiditis: a meta-analysis. Endocr. J. 2012, 59(12):1041-1050.
14. Pérez-García A., Osca G., Bosch-Vizcaya A., Kelleher N., Santos N.Y., Rodríguez R., González Y., Roncero J.M., Coll R., Serrando M., Lloveras N., Tuset E., Gallardo D. Kinetics of the CTLA-4 isoforms expression after T-lymphocyte activation and role of the promoterpolymorphisms on CTLA-4 gene transcription. Hum. Immunol. 2013, 74(9):1219-1224.
15. Rudd C.E., Taylor A., Schneider H. CD28 and CTLA-4 coreceptor expression and signal transduction. Immunol. Rev. 2009, 229(1):12-26.
16. Si X., Zhang X., Tang W., Luo Y. Association between the CTLA-4+49A/G polymorphism and Graves' disease: a meta-analysis. Exp. Ther. Med. 2012, 4(3):538-554.
17. Simmonds M.J. GWAS in autoimmune thyroid disease: redefining our under-standing of pathogenesis. Nat. Rev. Endocrinol. 2013, 9(5):277-287.
18. Takahashi M., Kimura A. HLA and CTLA4 polymorphisms may confer a synergistic risk in the susceptibility to Graves' disease. J. Hum. Genet. 2010, 55(5):323-326.
19. Tomer Y. Unraveling the genetic susceptibility to auto-immune thyroid disease: CTLA-4 takes the stage. Thyroid 2001, 11(2):167-169.
20. Tomer Y., Greenberg D.A., Barbesino G., Conception E.S., Davies T.F. CTLA-4 and not CD28 is a susceptibility gene for thyroid autoantibody production. J. Clin. Endocrinol. Metab. 2001, 86(4):1687-1693.
21. Tomer Y., Ban Y., Concepcion G., Barbesino G., Villanueva R., Greenberg D.A., Davies T.F. Common and unique susceptibility loci in Graves and Hashimoto disease: results of whole-genome screening in a data set of 102 multiplex families. Am. J. Hum. Genet. 2003, 73(4):736-747.
22. Ueda H., Howson J.M., Esposito L., Heward J., Snook H., Chamberlain G., Rainbow D.B., Hunter K.M., Smith A.N., Di Genova G., Herr M.H., Dahlman I., Payne F., Smyth D., Lowe C., Twells R.C., Howlett S., Healy B., Nutland S., Rance H.E., Everett V., Smink L.J., Lam A.C., Cordell H.J., Walker N.M., Bordin C., Hulme J., Motzo C., Cucca F., Hess J.F., Metzker M.L., Rogers J., Gregory S., Allahabadia A., Nithiyananthan R., Tuomilehto-Wolf E., Tuomilehto J., Bingley P., Gillespie K.M., Undlien D.E., Ronningen K.S., Guja C., Ionescu-Tîrgovişte C., Savage D.A., Maxwell A.P., Carson D.J., Patterson C.C., Franklyn J.A., Clayton D.G., Peterson L.B., Wicker L.S., Todd J.A., Gough S.C. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003, 423(6939):506-511.
23. Wang Y., Zhang J., Zhang J.A. Expression of CTLA-4 andCD40Lon periperal T lymphocytes in autoimmune thyroid disease. J. Fourth Mil. Med. Univ. 2009, 30:1791-1793.
24. Wang F.M., Chen X.M., Hao C., Tang H.B., Shen Q., Xu X.Y., Xu X.G., Qian H., Li Q., Yao P., Li J.H., Chen L. Costimulatory molecule CD40 expression in thyroid tissue of Graves' disease patients and its immune pathogenetic significance. Natl. Med. J. China 2013, 93(10):764-767.
25. Wang H.N., Jiang H., Liu W., Ye X.P., Pan C.M., Zhao S.X., Song H.D. SNP in 5'untranslated regions was related to Graves' disease in Chinese Han population. The 12th National Endocrinology Conference of Chinese Medical Association 2013, 119:OR06.
26. Yang J., Qin Q., Yan N., Zhu Y.F., Li C., Yang X.J., Wang X., Pandey M., Hou P., Zhang J.A. CD40 C/T(-1) and CTLA-4 A/G(49) SNPs are associated with autoimmune thyroid diseases in the Chinese population. Endocrine 2012, 41(1):111-115.
27. Zhu R., Liu G., Li W., Wang Z., Chen H., Zhang W. A study of costimulatory molecules in allergic allergic rhinitis patients. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2008, 22(17):780-2,784.